Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLC.
Bmc Medicine
Sun, Yiting Y; Duan, Jianchun J; Fang, Wenfeng W; Wang, Zhijie Z; Du, Xinyang X; Wang, Xin X; Li, Chengcheng C; Cai, Shangli S; Zhao, Jie J; Li, Sini S; Zhang, Li L; Bai, Hua H; Wang, Jie J